You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for PEG 3350 AND ELECTROLYTES


✉ Email this page to a colleague

« Back to Dashboard


PEG 3350 AND ELECTROLYTES

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novel Labs Inc PEG 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 090231 ANDA Novel Laboratories, Inc. 40032-090-19 274.31 g in 1 BOTTLE (40032-090-19) 2009-06-01
Novel Labs Inc PEG 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 090231 ANDA Lupin Pharmaceuticals,Inc. 43386-090-19 274.31 g in 1 BOTTLE (43386-090-19) 2009-06-01
Novel Labs Inc PEG 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 090186 ANDA Lupin Pharmaceuticals,Inc. 43386-060-19 278.26 g in 1 BOTTLE (43386-060-19) 2009-01-06
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: PEG 3350 and Electrolytes

Last updated: July 30, 2025


Introduction

Polyethylene glycol 3350 (PEG 3350) combined with electrolytes is a widely used formulation for bowel cleansing, particularly in preparation for colonoscopy procedures. The global demand for this pharmaceutical compound has led to a complex supplier landscape, comprising raw material producers, active pharmaceutical ingredient (API) manufacturers, and finished drug formulators. For healthcare providers, pharmaceutical companies, and investors, understanding the key suppliers in this supply chain is essential for ensuring procurement stability, quality, and competitive pricing.


Overview of PEG 3350 and Electrolytes in Pharmaceuticals

PEG 3350 is a high-molecular-weight polyethylene glycol, primarily used as a laxative component due to its osmotic properties (see [1] for detailed chemistry). Paired with electrolytes such as sodium chloride, sodium bicarbonate, and potassium chloride, it forms an effective bowel prep solution—marketed as MiraLAX or Golytely among other brands ([2]).

The manufacturing of PEG 3350 involves complex polymerization processes, demanding high-purity raw materials and stringent quality controls. Electrolytes are typically sourced from large mineral suppliers, with manufacturing standards aligned with pharmacopeias such as the USP or EP.


Key Raw Material Suppliers for PEG 3350

The supply chain for PEG 3350 begins with the procurement of ethylene oxide, the primary monomer used in polyethylene glycol synthesis.

1. Ethylene Oxide Suppliers

Major global players in ethylene oxide production include:

  • Dow Chemical Company (Dow Inc.): A leading producer with extensive facilities across North America, Europe, and Asia-Pacific. Dow supplies high-purity ethylene oxide essential for pharmaceutical-grade PEG ([3]).

  • Shell Chemicals: An established ethylene oxide producer offering raw materials suitable for pharmaceutical PEG manufacturing, with strict quality standards ([4]).

  • LyondellBasell: A significant player with capacities tailored towards specialty applications, including pharmaceutical-grade ethylene oxide ([5]).

  • Sabic: Noted for its specialization in high-purity ethylene oxide, particularly serving Asia-Pacific markets ([6]).

2. PEG 3350 Active Ingredient Manufacturers

While some companies produce PEG 3350 directly as an API, much of the bulk production is handled by specialized chemical manufacturers:

  • Piramal Enterprises: A major pharmaceutical contract manufacturer manufacturing PEG-based products, including PEG 3350, under stringent quality controls ([7]).

  • BASF: Offers PEG derivatives and high-purity polyethylene glycol grades suitable for pharmaceutical use.

  • Evonik Industries: Produces PEG products under the Polyglycol trademark, with a focus on high purity for medical applications ([8]).

  • Ashland Global Holdings: Provides PEG materials that are used in pharmaceutical formulations, including PEG 3350 variants.

3. Electrolyte Raw Material Suppliers

Electrolytes such as sodium chloride, sodium bicarbonate, and potassium chloride originate from mineral extraction:

  • Cargill: One of the world's largest producers of salt and mineral-based electrolytes, supplying pharmaceutical-grade products ([9]).

  • Tata Chemicals: Provides high-purity electrolytes compliant with pharmacopeial standards, serving global markets ([10]).

  • Nutrien Ltd.: A significant supplier of specialty salts and electrolytes, including pharmaceutical-grade variants ([11]).

  • American Elements: Supplies high-purity electrolytes suitable for medical applications, ensuring consistent quality ([12]).


Manufacturing and Regulatory Standards

Suppliers of PEG 3350 and electrolytes must adhere to strict pharmacopeial standards such as USP, EP, or JP, ensuring purity, consistency, and safety. This entails robust manufacturing practices, extensive quality control, and validation protocols.

Major suppliers invest heavily in ISO certifications, cGMP compliance, and validation processes to meet the rigorous demands of the pharmaceutical industry. These standards influence supplier selection, especially for companies seeking reliable, high-quality raw materials.


Market Dynamics and Supply Chain Considerations

The supply landscape for PEG 3350 and electrolytes is affected by:

  • Global demand fluctuations, especially due to increased screening and aging populations requiring colonoscopy prep.

  • Raw material price volatility, driven by oil and natural gas costs affecting ethylene oxide prices and mineral salt markets.

  • Geopolitical factors impacting supply routes, particularly from regions with concentrated manufacturing bases like Asia-Pacific, North America, and Europe.

  • Regulatory compliance and quality standards, which can act as barriers to entry for new suppliers and influence procurement decisions.

Additionally, supply chain resilience has become a strategic priority, with companies seeking diversified sourcing and establishing reliable supplier relationships.


Leading Companies and Strategic Relationships

Large pharmaceutical players, such as Baxter International, Ferring Pharmaceuticals, and Revive Therapeutics, often partner with multiple raw material providers to mitigate risks. Contract manufacturing organizations (CMOs) also play a crucial role, sourcing raw materials from globally recognized suppliers to produce high-quality PEG 3350 formulations.

Furthermore, peer-reviewed supply agreements and long-term contracts mitigate disruptions, especially during supply constraints or global crises like the COVID-19 pandemic.


Emerging Suppliers and Innovation

Innovations in PEG synthesis and electrolyte formulations include bio-based and more sustainable raw materials. Companies such as Carbogen Amcis and Core Genesis are exploring novel manufacturing pathways, sometimes partnering with raw material suppliers to develop proprietary formulations with improved efficacy or reduced environmental impact.


Conclusion

The supply chain for PEG 3350 and electrolytes involves a complex network of raw material producers, chemical manufacturers, and formulators operating under stringent quality standards. Top raw material suppliers include Dow, Shell, LyondellBasell, Cargill, Tata Chemicals, and American Elements, providing high-purity ethylene oxide and mineral salts. Pharmaceutical-grade PEG 3350 manufacturers—such as Piramal, BASF, Evonik, and Ashland—source these raw materials to produce APIs that meet rigorous regulatory standards. Given market volatility and regulatory landscapes, diversification of suppliers and robust quality assurance processes are essential to maintaining supply chain stability for this critical pharmaceutical product.


Key Takeaways

  • Diverse supplier base: Critical raw materials for PEG 3350 and electrolytes come from globally recognized suppliers, demanding high-quality standards.

  • Regulatory compliance: Suppliers must adhere to pharmacopeial standards (USP, EP), influencing sourcing decisions.

  • Market resilience: Supply chain stability hinges on diversified sourcing, long-term contracts, and transparency.

  • Emerging innovation: Sustainability and new synthesis pathways are shaping future supply options.

  • Strategic importance: Reliable suppliers directly impact the quality, cost, and supply stability of bowel prep medications.


FAQs

1. Who are the top suppliers of ethylene oxide for PEG 3350 production?
Major ethylene oxide suppliers include Dow Chemical, Shell Chemicals, LyondellBasell, Sabic, and some regional producers in Asia-Pacific such as LG Chem.

2. What are the main electrolytes used with PEG 3350 in pharmaceuticals?
Primarily sodium chloride, sodium bicarbonate, and potassium chloride, sourced from mineral salt producers like Cargill, Tata Chemicals, and Nutrien.

3. How do regulatory standards affect supplier choice?
Suppliers must provide materials meeting USP, EP, or JP standards, necessitating rigorous quality assurance, audits, and compliance documentation.

4. Are there sustainable alternatives or innovations in PEG 3350 supply chain?
Yes, research focuses on bio-based PEG production and environmentally friendly electrolytes, although widespread adoption remains emerging.

5. How does geopolitical stability influence production and supply?
Manufacturing concentration in regions like North America, Europe, and Asia-Pacific affects supply reliability; disruptions or trade barriers can impact availability.


References

[1] Johnson, B. (2020). “Polyethylene Glycol Chemistry and Pharmaceutical Applications,” PharmaChem Review.
[2] U.S. Pharmacopeia. (2022). USP Monographs for PEG and Bowel Prep Solutions.
[3] Dow Inc. Ethylene Oxide Product Data Sheet. (2022).
[4] Shell Chemicals. Ethylene Oxide Overview. (2021).
[5] LyondellBasell. Specialty Chemicals Portfolio. (2021).
[6] Sabic. High-Purity Ethylene Oxide Products. (2022).
[7] Piramal Enterprises. Contract Manufacturing Capabilities. (2022).
[8] Evonik Industries. PEG Derivatives Portfolio. (2021).
[9] Cargill. Salt and Electrolytes Supply Chain. (2022).
[10] Tata Chemicals. High-Purity Electrolytes for Pharma. (2021).
[11] Nutrien Ltd. Pharmaceutical-Grade Salts. (2022).
[12] American Elements. Specialty Electrolytes for Medical Applications. (2022).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.